Carolyn L. Ruby

1.4k citations

19 papers · 1.1k indexed · 1 hit paper · h-index 13

Impact in

Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
Biotechnology top 5%
- Microbial Metabolism and Applications

Papers in ⓘ

Molecular Medicine 3
- Antibiotic Resistance in Bacteria 3
Aging 1

Co-authors: Patrice H. Gibbons (3 shared papers)Tanya MacNeil (2 shared papers)Keith M. Gewain (2 shared papers)Douglas J. MacNeil (2 shared papers)Gabe Dezeny (1 shared paper)James Occi (1 shared paper)L. Riesel (3 shared papers)Marvin D. Schulman (2 shared papers)
Journals: The Journal of Antibiotics (3 papers)Gene (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Industrial Microbiology & Biotechnology (2 papers)Tetrahedron Letters (1 paper)
Partner nations: United States Spain Germany

In The Last Decade

Carolyn L. Ruby

18 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector 1992 · 635 citations

Peers

Countries citing papers authored by Carolyn L. Ruby

Since Specialization

Citations

This map shows the geographic impact of Carolyn L. Ruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn L. Ruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn L. Ruby more than expected).

Fields of papers citing papers by Carolyn L. Ruby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn L. Ruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn L. Ruby. The network helps show where Carolyn L. Ruby may publish in the future.

Co-authors

The 25 scholars most cited alongside Carolyn L. Ruby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carolyn L. Ruby Line = papers co-authored together Carolyn L. Ruby links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector Gene ·Douglas J. MacNeil, Keith M. Gewain, Carolyn L. Ruby, Gabe Dezeny, Patrice H. Gibbons, Tanya MacNeil Hit paper breakdown →	1992	635
2	Complex organization of the Streptomyces avermitilis genes encoding the avermectin polyketide synthase Gene ·Douglas J. MacNeil, James Occi, Keith M. Gewain, Tanya MacNeil, Patrice H. Gibbons, Carolyn L. Ruby, Susan J. Danis	1992	156
3	Mutants of a lovastatin-hyperproducingAspergillus terreus deficient in the production of sulochrin Journal of Industrial Microbiology & Biotechnology ·Victor A. Vinci, T. D. Hoerner, Allen D. Coffman, Timothy G. Schimmel, Rebecca Dabora, A. C. Kirpekar, Carolyn L. Ruby, R. W. Stieber	1991	48
4	Isolation and structure elucidation of coleophomones A and B, novel inhibitors of bacterial cell wall transglycosylase Tetrahedron Letters ·Kenneth E. Wilson, Nancy N. Tsou, Ziqiang Guan, Carolyn L. Ruby, Fernando Peláez, Julian Gorrochategui, Francisca Vicente, Hiroshi Ōnishi	2000	38
5	Anthrabenzoxocinones from Streptomyces sp. as Liver X Receptor Ligands and Antibacterial Agents Journal of Natural Products ·Kithsiri Herath, Hiranthi Jayasuriya, Ziqiang Guan, Marvin Schulman, Carolyn L. Ruby, Neelam Sharma, Karen L. MacNaul, John G. Menke, Srinivas Kodali, Andrew Galgoci, Jun Wang, Sheo B. Singh	2005	35
6	Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease Biochemical and Biophysical Research Communications ·Sheo B. Singh, John G. Ondeyka, Nasios Tsipouras, Carolyn L. Ruby, Vinod Sardana, Marvin Schulman, Manuel Almagro Sánchez, Fernando Peláez, Mark W. Stahlhut, Sanjeev Munshi, David B. Olsen, Russell B. Lingham	2004	33
7	Brine shrimp (Artemia salina) as a convenient bioassay for avermectin analogs. The Journal of Antibiotics ·Timothy A. Blizzard, Carolyn L. Ruby, Helmut Mrozik, Franz A. Preiser, Michael H. Fisher	1989	28
8	Isolation and characterization of the Streptomyces cattleya temperate phage TG1 Gene ·F Foor, Gary P. Roberts, Nancy R. Morin, Linda C. Snyder, Margaret Hwang, Patrice H. Gibbons, Mary Jo Paradiso, Ronald L. Stotish, Carolyn L. Ruby, B. Wolanski, Stanley L. Streicher	1985	28
9	Ester der Imidodiphosphorsäure Zeitschrift für anorganische und allgemeine Chemie ·L. Riesel, G. Pich, Carolyn L. Ruby	1977	23
10	Citrafungins A and B, Two New Fungal Metabolite Inhibitors of GGTase I with Antifungal Activity Organic Letters ·Sheo B. Singh, Deborah L. Zink, George A. Doss, Jon D. Polishook, Carolyn L. Ruby, Elizabeth Register, Theresa M. Kelly, Cynthia Bonfiglio, Joanne M. Williamson, Rosemarie Kelly	2004	20
11	"Streptomyces avermitilis" mutants defective in methylation of avermectins Antimicrobial Agents and Chemotherapy ·Marvin D. Schulman, Delia Valentino, S L Streicher, Carolyn L. Ruby	1987	19
12	Minocycline Resistance in Staphylococcus aureus: Effect on Phage Susceptibility Antimicrobial Agents and Chemotherapy ·S. Schaefler, W. Francois, Carolyn L. Ruby	1976	15
13	Zur Konstitution der Trimethylsilylderivate von Imidodiphosphorylverbindungen Zeitschrift für anorganische und allgemeine Chemie ·L. Riesel, A. Claussnitzer, Carolyn L. Ruby	1977	12
14	Methylation of demethylavermectins Antimicrobial Agents and Chemotherapy ·Marvin D. Schulman, Carolyn L. Ruby	1987	9
15	Untersuchungen zur Phosphorylierung von Imidodiphosphorsäurederivaten Zeitschrift für anorganische und allgemeine Chemie ·L. Riesel, A. Claussnitzer, Carolyn L. Ruby, P. Kindscherowsky	1977	4
16	Mutants of Streptomyces cattleya defective in the synthesis of a factor required for thienamycin production. The Journal of Antibiotics ·TIM BUCHAN, Claudia Roach, Carolyn L. Ruby, D. C. Taylor, Carol L. Preisig, Christopher D. Reeves	1994	4
17	A cofactor for thienamycin biosynthesis produced by a blocked mutant ofStreptomyces cattleya Journal of Industrial Microbiology & Biotechnology ·Tom S. Chen, Byron H. Arison, Carolyn L. Ruby, Anne W. Dombrowski, Edward Inamine	1993	4
18	In vitro development of resistance to fosfomycin. The Journal of Antibiotics ·Eugene L. Dulaney, Carolyn L. Ruby	1977	4
19	Citrafungins A and B, Two New Fungal Metabolite Inhibitors of GGTase I with Antifungal Activity. ChemInform ·Sheo B. Singh, Deborah L. Zink, George A. Doss, Jon D. Polishook, Carolyn L. Ruby, Elizabeth Register, Theresa M. Kelly, Cynthia Bonfiglio, Joanne M. Williamson, Rosemarie Kelly	2004	0

About Carolyn L. Ruby

Carolyn L. Ruby is a scholar working on Molecular Medicine, Aging, Pharmacology, Biotechnology and Toxicology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Genomics and Phylogenetic Studies (3 papers), Synthesis and characterization of novel inorganic/organometallic compounds (3 papers), Antibiotic Resistance in Bacteria (3 papers), Organophosphorus compounds synthesis (3 papers), Plant Disease Resistance and Genetics (3 papers), Cancer therapeutics and mechanisms (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Pharmacology (729 citations), Biotechnology (187 citations), Molecular Biology (715 citations), Organic Chemistry (264 citations) and Molecular Medicine (37 citations). Carolyn L. Ruby has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Patrice H. Gibbons, Tanya MacNeil, Keith M. Gewain, Douglas J. MacNeil, Gabe Dezeny, James Occi, L. Riesel, Marvin D. Schulman, Sheo B. Singh and Fernando Peláez. Their work appears in journals such as The Journal of Antibiotics, Gene, Antimicrobial Agents and Chemotherapy, Journal of Industrial Microbiology & Biotechnology and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact